Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

Dr. Zitelli emphasized that "Mohs surgery" should only be called that when one doctor does both the surgery and pathology.

Hair restoration should focus on quality and value, not cost, to maintain the field's reputation and ensure patient satisfaction.

This abstract is from a website with no specific study or research content, focusing on access to JAMA publications and administrative information.

This article reviews four books on pediatric dermatopathology, photodamage, photoimmunology, and hair and scalp disorders, reporting no new research findings.

This letter discusses the importance of microvascular disease in renal arterioles as a common cause of renal failure progressing to end-stage renal disease, a topic often overlooked in nephrology literature.

The book is a valuable reference on androgenic disorders for professionals but not suitable for laypeople or medical students.

This article reviews challenges and errors in performing Mohs surgery, emphasizing vigilance in maintaining its procedural integrity for successful treatment outcomes, and reports no new clinical findings.

This study observed that a 2% topical minoxidil solution was beneficial in 63% of male patients with androgenic alopecia, although only 6.6% experienced dramatic cosmetic improvement.

A woman successfully sued for not being told about a medication's side effects, emphasizing doctors' duty to inform patients.

This report adds two cases of total ovarian pigmentation, with no associated symptoms or pathological findings, to the previously reported unilateral case.

This article discusses a forthcoming advertising campaign for minoxidil, highlighting the need for dermatologists to understand its efficacy, with reports showing it was significantly superior to placebo in promoting hair growth at four months.

This letter challenges Dr. Dubois' statement that nearly all patients with Raynaud phenomenon will develop a systemic disorder, arguing that many experience it without progressing to serious disease.

This article reviews the terminology and factors associated with female hair loss, particularly distinguishing it from male pattern hair loss, but reports no new clinical results.

This review discusses treatments for androgenetic alopecia, recommending Minoxidil, Finasteride, and Dutasteride as first-line therapies, and highlights the potential of JAK inhibitors for future permanent cures.

This study found that adding microneedling with low-level LED therapy and growth factors to Finasteride® treatment led to significant hair regrowth and increased hair density in patients with androgenic alopecia.

This preliminary study found that combining 5% minoxidil with 2% flutamide was associated with increased hair thickness in patients with androgenetic alopecia compared to 5% minoxidil alone.

In this study, researchers reported that androgenetic alopecia is associated with significantly decreased quality of life, particularly impacting younger patients and those with severe or long-standing hair loss.

In this prospective study, combining 5% topical minoxidil with platelet rich plasma provided more significant improvements in hair parameters for male baldness than platelet rich plasma alone over six months.

This study found that using a combination of 10% topical minoxidil, oral finasteride, and microneedling for six months effectively improved male pattern baldness with moderate to excellent responses and high patient satisfaction, without major side effects among the 25 participants.

This meta-analysis found that patients with androgenetic alopecia have an atherogenic lipid profile, with higher LDL, triglycerides, and total cholesterol, and lower HDL, potentially explaining increased cardiovascular risk.

Microneedling with PRP and minoxidil (5%) improves hair growth more than minoxidil (5%) alone.

Dutasteride and finasteride have equal safety for treating BPH without increased heart risk.

Finasteride for hair loss may cause long-lasting sexual side effects in young males.

This article discusses the side effects of androgen deprivation therapy for nonmetastatic prostate cancer, highlighting the need for clinical trials to systematically study these effects.

This study observed that patients receiving IL-2 immunotherapy developed a skin eruption characterized by burning and pruritus, which resolved shortly after stopping the infusion, suggesting that IL-2 mediated these effects.

This review discusses evidence-based guidance for managing primary cicatricial alopecias but reports no new clinical results, highlighting significant gaps in knowledge and the need for more quality trials.

This review highlights the challenges in identifying histological features of adverse reactions to soft tissue fillers and emphasizes the need for increased awareness due to product uncertainty and delayed reactions.

This article addresses the need to screen for nutrient deficiencies in patients with hair loss but reports no new findings, noting that supplementation without deficiency may not be beneficial and could pose risks.

This review outlines the steps of contemporary hair transplantation surgery, including the roles of medications and nonsurgical options, but it reports no new clinical findings.

This report discusses the various causes and clinical assessment of madarosis, emphasizing the importance of recognizing and diagnosing associated vision or life-threatening conditions, without presenting new findings.